Total Payments
$258,794
2024 Payments
$62,932
Companies
13
Transactions
374
Medicare Patients
371
Medicare Billing
$35,364
Payment Breakdown by Category
Other$210,945 (81.5%)
Travel$28,378 (11.0%)
Food & Beverage$12,386 (4.8%)
Consulting$7,080 (2.7%)
Education$5.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $185,105 | 76 | 71.5% |
| Travel and Lodging | $28,378 | 153 | 11.0% |
| Honoraria | $25,840 | 9 | 10.0% |
| Food and Beverage | $12,386 | 131 | 4.8% |
| Consulting Fee | $7,080 | 4 | 2.7% |
| Education | $5.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARGENX US, INC. | $115,242 | 166 | $0 (2024) |
| Grifols USA, LLC | $80,025 | 112 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $30,491 | 34 | $0 (2022) |
| UCB, Inc. | $17,052 | 29 | $0 (2024) |
| Octapharma USA, Inc. | $10,967 | 13 | $0 (2022) |
| CSL Behring | $3,214 | 8 | $0 (2018) |
| Harmony Biosciences LLC | $1,214 | 2 | $0 (2020) |
| Biogen, Inc. | $245.09 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $121.68 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $116.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,932 | 86 | ARGENX US, INC. ($39,259) |
| 2023 | $75,586 | 109 | ARGENX US, INC. ($54,594) |
| 2022 | $30,832 | 42 | ARGENX US, INC. ($21,388) |
| 2021 | $11,761 | 11 | CATALYST PHARMACEUTICALS, INC. ($7,812) |
| 2020 | $25,263 | 25 | CATALYST PHARMACEUTICALS, INC. ($17,613) |
| 2019 | $17,016 | 33 | Grifols USA, LLC ($11,732) |
| 2018 | $19,694 | 35 | Grifols USA, LLC ($16,350) |
| 2017 | $15,711 | 33 | Grifols USA, LLC ($10,131) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology and Neurology | ||||||
| 12/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $96.44 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $203.68 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $109.88 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Travel and Lodging | Cash or cash equivalent | $56.28 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,990.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $526.96 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $194.77 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | Cash or cash equivalent | $125.17 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Rystiggo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: Neurology | ||||||
| 11/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $194.26 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Neurology | ||||||
| 10/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Neurology | ||||||
| 10/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $149.40 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 64 | 76 | $31,770 | $7,502 |
| 2022 | 1 | 61 | 70 | $25,519 | $5,772 |
| 2021 | 4 | 120 | 141 | $35,282 | $11,045 |
| 2020 | 5 | 126 | 139 | $44,561 | $11,046 |
Total Patients
371
Total Services
426
Medicare Billing
$35,364
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 48 | $17,428 | $4,106 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 28 | $14,342 | $3,396 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 70 | $25,519 | $5,772 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 40 | $13,254 | $3,747 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 55 | $12,928 | $3,251 | 25.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 31 | 35 | $4,096 | $2,797 | 68.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $5,004 | $1,250 | 25.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 53 | $16,557 | $4,088 | 24.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 39 | 43 | $17,820 | $3,347 | 18.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 18 | 20 | $1,820 | $1,451 | 79.7% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2020 | 11 | 11 | $4,532 | $1,127 | 24.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $3,832 | $1,033 | 26.9% |
About Dr. Rossitza Chichkova, MD
Dr. Rossitza Chichkova, MD is a Neurology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235148263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rossitza Chichkova, MD has received a total of $258,794 in payments from pharmaceutical and medical device companies, with $62,932 received in 2024. These payments were reported across 374 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($185,105).
As a Medicare-enrolled provider, Chichkova has provided services to 371 Medicare beneficiaries, totaling 426 services with total Medicare billing of $35,364. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Tampa, FL
- Active Since 08/07/2006
- Last Updated 09/28/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1235148263
Products in Payments
- VYVGART (Drug) $87,117
- Gamunex-C (Biological) $80,095
- VYVGART HYTRULO (Drug) $28,124
- FIRDAPSE (Drug) $26,716
- Rystiggo (Drug) $16,186
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $5,574
- OCTAGAM (Biological) $5,393
- Hizentra (Biological) $3,214
- Wakix (Drug) $1,214
- Zilbrysq (Drug) $840.00
- SPINRAZA (Biological) $131.57
- SOLIRIS (Drug) $121.68
- AFINITOR (Drug) $116.94
- TECFIDERA (Drug) $113.52
- APTIOM (Drug) $10.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tampa
Derrick Robertson, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
Selim Benbadis, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Dr. Mark Cascione, M.d, M.D
Neurology — Payments: $1.9M
Neurology $1.9M
Robert Hauser, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
David Rose, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Katherine Standley, Do, DO
Neurology — Payments: $1.3M
Neurology $1.3M